| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.091 | 0.009 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.009 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |